Related Experiment Video
Updated: Jun 13, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate,
Louis Saravolatz1, Joan Pawlak, Leonard Johnson
1St. John Hospital and Medical Center, 19251 Mack Ave., Suite 333, Detroit, MI 48236, USA. louis.saravolatz@stjohn.org
Abstract:
This study assessed the in vitro activities of ceftaroline and five comparator agents against a collection of Staphylococcus aureus isolates. Ceftaroline demonstrated potent activity against community-associated methicillin-resistant S. aureus (CA-MRSA) isolates and showed bactericidal activity against vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA), heteroresistant VISA (hVISA), and daptomycin-nonsusceptible S. aureus (DNSSA) isolates. Ceftaroline may represent a bactericidal treatment option for infections caused by these pathogens.
Insights
Ceftaroline shows strong in vitro activity against various resistant Staphylococcus aureus strains, including community-associated methicillin-resistant S. aureus (CA-MRSA). It also demonstrated bactericidal effects against difficult-to-treat isolates, offering a potential new treatment option.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Staphylococcus aureus is a significant human pathogen.
- Increasing antimicrobial resistance in S. aureus poses a therapeutic challenge.
- Novel antibiotics are needed to combat resistant strains.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of ceftaroline.
- To compare ceftaroline's efficacy against various resistant Staphylococcus aureus phenotypes.
- To assess ceftaroline's bactericidal potential against challenging S. aureus isolates.
Main Methods:
- In vitro susceptibility testing of ceftaroline and comparator agents.
- Testing against a diverse collection of Staphylococcus aureus isolates.
- Characterization of isolates including CA-MRSA, VISA, VRSA, hVISA, and DNSSA.
Main Results:
- Ceftaroline exhibited potent activity against community-associated methicillin-resistant S. aureus (CA-MRSA).
- Ceftaroline demonstrated bactericidal activity against vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA), heteroresistant VISA (hVISA), and daptomycin-nonsusceptible S. aureus (DNSSA).
Conclusions:
- Ceftaroline possesses significant in vitro activity against a range of resistant S. aureus.
- The drug shows promise as a bactericidal agent for infections caused by these difficult-to-treat pathogens.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness